Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endoscopic therapy for Barrett's esophagus.

Ronald W Yeh1, George Triadafilopoulos

  • 1Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Alway Building M-211, CA 94305, USA. yehr@stanford.edu

Gastrointestinal Endoscopy Clinics of North America
|July 2, 2005
PubMed
Summary

Endoscopic therapies aim to manage Barrett's esophagus, a precursor to esophageal adenocarcinoma. However, residual intestinal metaplasia poses a persistent risk for neoplastic progression, necessitating further research into effective treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional and Anatomical Significance of Patulous Anus.

Digestive diseases and sciences·2026
Same author

DAT's Amazing-Ampullary Repositioning of an Intra-diverticular Papilla Facilitating Successful ERCP and Biliary Drainage.

Digestive diseases and sciences·2026
Same author

A Bloody Mimic of Crohn's Disease: Primary Intestinal EBV-Positive NK/T-Cell Lymphoma.

Digestive diseases and sciences·2026
Same author

Potassium competitive acid blockers in Barrett's esophagus: lessons from gastro-esophageal reflux disease and future directions.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same author

Antireflux Surgery for Barrett's Esophagus: Where Do We Stand in Preventing Esophageal Adenocarcinoma?

Annals of the New York Academy of Sciences·2026
Same author

Esophageal Acid Suppression Unmasks Latent Esophageal Acid-Symptom Phenotypes in GERD.

Digestive diseases and sciences·2026

Area of Science:

  • Gastroenterology
  • Oncology
  • Endoscopic Surgery

Background:

  • Rising rates of esophageal adenocarcinoma in Western countries.
  • High morbidity and mortality associated with esophagectomy.
  • Need for effective treatments and prevention strategies for esophageal adenocarcinoma.

Purpose of the Study:

  • Review current endoscopic therapies for Barrett's esophagus management.
  • Evaluate the long-term efficacy of these treatments.
  • Assess the risk of neoplastic progression after endoscopic therapy.

Main Methods:

  • Comprehensive review of published literature on endoscopic therapies for Barrett's esophagus.
  • Analysis of studies reporting on long-term outcomes and neoplastic risk.
  • Focus on specialized intestinal metaplasia persistence and neo-squamous mucosa.

Related Experiment Videos

Main Results:

  • Various endoscopic mucosal ablative techniques exist for early esophageal neoplasia.
  • Long-term control of neoplastic risk has not been definitively demonstrated.
  • Specialized intestinal metaplasia can persist beneath neo-squamous mucosa, indicating ongoing risk.

Conclusions:

  • Current endoscopic therapies for Barrett's esophagus require further evaluation for long-term efficacy.
  • The persistence of specialized intestinal metaplasia is a significant concern.
  • Ongoing research is crucial for developing improved strategies to prevent esophageal adenocarcinoma progression.